Cabot Wealth Management Boosted Abiomed (ABMD) Position by $866,121; Stock Declined; As Crown Castle Intl (CCI) Valuation Rose, Holder Ashfield Capital Partners Has Increased Stake

Crown Castle International Corp. (NYSE:REIT) Logo

Cabot Wealth Management Inc increased its stake in Abiomed Inc (ABMD) by 86.66% based on its latest 2018Q3 regulatory filing with the SEC. Cabot Wealth Management Inc bought 1,929 shares as the company’s stock declined 16.71% with the market. The institutional investor held 4,155 shares of the health care company at the end of 2018Q3, valued at $1.87M, up from 2,226 at the end of the previous reported quarter. Cabot Wealth Management Inc who had been investing in Abiomed Inc for a number of months, seems to be bullish on the $15.38 billion market cap company. The stock decreased 0.12% or $0.4 during the last trading session, reaching $341.21. About 307,537 shares traded. ABIOMED, Inc. (NASDAQ:ABMD) has risen 72.24% since February 11, 2018 and is uptrending. It has outperformed by 72.24% the S&P500. Some Historical ABMD News: 08/03/2018 – ABIOMED – ON MARCH 6, ENTERED SETTLEMENT WITH U.S. DOJ RESOLVING CLAIMS ON CO’S REIMBURSEMENT OF EMPLOYEE EXPENSES FOR MEALS WITH HEALTHCARE PROVIDERS; 02/04/2018 – Abiomed Receives FDA Approval for Impella CP(R) With SmartAssist(TM) and Optical Sensor; 14/05/2018 – Winslow Capital Buys New 1.8% Position in Abiomed; 03/05/2018 – Abiomed 4Q EPS 80c; 03/05/2018 – ABIOMED SEES FY REV. $740.0M TO $770.0M, EST. $747.3M; 03/05/2018 – Abiomed 4Q Rev $174.4M; 05/04/2018 – Abiomed Announces European Approval (CE Marking) for lmpella 5.5(TM) and First Patient Treated at University Heart Center Hamburg; 03/05/2018 – ABIOMED 4Q EPS 80C, EST. 64C; 04/04/2018 – Abiomed Announces European Approval (CE Marking) for Impella 5.5™ and First Patient Treated at University Heart Center; 05/04/2018 – ABIOMED ANNOUNCES EUROPEAN APPROVAL (CE MARKING) FOR IMPELLA 5.5(TM) AND FIRST PATIENT TREATED AT UNIVERSITY HEART CENTER HAMBURG

Ashfield Capital Partners Llc increased its stake in Crown Castle Intl Corp (CCI) by 12.33% based on its latest 2018Q3 regulatory filing with the SEC. Ashfield Capital Partners Llc bought 9,151 shares as the company’s stock rose 3.08% while stock markets declined. The institutional investor held 83,343 shares of the real estate investment trusts company at the end of 2018Q3, valued at $9.28M, up from 74,192 at the end of the previous reported quarter. Ashfield Capital Partners Llc who had been investing in Crown Castle Intl Corp for a number of months, seems to be bullish on the $49.11B market cap company. The stock increased 0.08% or $0.09 during the last trading session, reaching $118.37. About 2.11M shares traded. Crown Castle International Corp. (NYSE:CCI) has risen 5.82% since February 11, 2018 and is uptrending. It has outperformed by 5.82% the S&P500.

Investors sentiment decreased to 1.21 in 2018 Q3. Its down 0.40, from 1.61 in 2018Q2. It is negative, as 35 investors sold ABMD shares while 144 reduced holdings. 77 funds opened positions while 139 raised stakes. 35.84 million shares or 0.84% less from 36.14 million shares in 2018Q2 were reported. Bp Public Ltd Liability Corp reported 0.06% stake. Driehaus Capital Mngmt Lc holds 6,021 shares or 0.08% of its portfolio. Great West Life Assurance Can has 0.03% invested in ABIOMED, Inc. (NASDAQ:ABMD) for 27,834 shares. Howe Rusling Incorporated stated it has 26 shares or 0% of all its holdings. Royal London Asset Management Limited holds 16,122 shares. Massachusetts-based Congress Asset Mgmt Ma has invested 0.22% in ABIOMED, Inc. (NASDAQ:ABMD). Wells Fargo Mn invested 0.02% in ABIOMED, Inc. (NASDAQ:ABMD). Menta Cap Ltd Liability owns 3,306 shares or 0.52% of their US portfolio. 1,855 were accumulated by Redwood Limited Liability. State Of Tennessee Treasury Department invested in 0.07% or 29,822 shares. Wilbanks Smith & Thomas Asset Management Ltd Llc has invested 0.06% in ABIOMED, Inc. (NASDAQ:ABMD). Robeco Institutional Asset Mgmt Bv owns 72,160 shares for 0.13% of their portfolio. Hl Finance Services Limited Liability accumulated 38,887 shares. Telemus Capital Limited Liability Corporation owns 2,081 shares. 1,545 are held by Beaumont Prtnrs Ltd.

Cabot Wealth Management Inc, which manages about $552.75M and $466.22 million US Long portfolio, decreased its stake in Cdw Corp (NASDAQ:CDW) by 3,537 shares to 97,276 shares, valued at $8.65 million in 2018Q3, according to the filing. It also reduced its holding in Apple Inc (NASDAQ:AAPL) by 1,826 shares in the quarter, leaving it with 66,162 shares, and cut its stake in Tjx Cos Inc New (NYSE:TJX).

More notable recent ABIOMED, Inc. (NASDAQ:ABMD) news were published by: Nasdaq.com which released: “ABMD Crosses Below Key Moving Average Level – Nasdaq” on October 25, 2018, also Nasdaq.com with their article: “Is ABIOMED (ABMD) Stock Outpacing Its Medical Peers This Year? – Nasdaq” published on January 25, 2019, Nasdaq.com published: “ABIOMED (ABMD) Q3 Earnings Beat, Impella Maintains Momentum – Nasdaq” on February 01, 2019. More interesting news about ABIOMED, Inc. (NASDAQ:ABMD) were released by: Nasdaq.com and their article: “Abiomed (ABMD) Stock Moves -0.81%: What You Should Know – Nasdaq” published on October 18, 2018 as well as Nasdaq.com‘s news article titled: “Abiomed (ABMD) Earnings Expected to Grow: Should You Buy? – Nasdaq” with publication date: January 24, 2019.

Since August 29, 2018, it had 0 buys, and 4 sales for $16.61 million activity. 5,000 shares valued at $2.10 million were sold by Greenfield Andrew J on Monday, September 24. 24,000 ABIOMED, Inc. (NASDAQ:ABMD) shares with value of $8.44M were sold by Weber David M.

Among 15 analysts covering Abiomed (NASDAQ:ABMD), 14 have Buy rating, 0 Sell and 1 Hold. Therefore 93% are positive. Abiomed had 40 analyst reports since August 4, 2015 according to SRatingsIntel. As per Monday, October 16, the company rating was downgraded by BTIG Research. The firm has “Buy” rating by Jefferies given on Thursday, February 1. The rating was maintained by SunTrust on Friday, February 16 with “Buy”. Raymond James upgraded the stock to “Outperform” rating in Friday, October 30 report. The company was maintained on Thursday, June 29 by Jefferies. Stephens maintained it with “Buy” rating and $30000 target in Monday, April 9 report. The rating was maintained by Stephens on Friday, February 2 with “Buy”. The rating was initiated by Guggenheim with “Buy” on Wednesday, December 7. The rating was maintained by Leerink Swann on Thursday, October 12 with “Buy”. Piper Jaffray maintained the shares of ABMD in report on Wednesday, August 5 with “Hold” rating.

Among 21 analysts covering Crown Castle International Corp (NYSE:CCI), 13 have Buy rating, 0 Sell and 8 Hold. Therefore 62% are positive. Crown Castle International Corp had 70 analyst reports since July 21, 2015 according to SRatingsIntel. The firm has “Hold” rating given on Tuesday, October 31 by KeyBanc Capital Markets. Bank of America maintained Crown Castle International Corp. (NYSE:REIT) on Friday, September 8 with “Buy” rating. As per Wednesday, July 19, the company rating was maintained by Oppenheimer. The firm earned “Buy” rating on Wednesday, December 6 by SunTrust. The firm has “Hold” rating by KeyBanc Capital Markets given on Monday, November 27. The firm has “Overweight” rating by Morgan Stanley given on Thursday, August 16. The rating was maintained by Stifel Nicolaus with “Buy” on Friday, July 22. The firm has “Hold” rating by Evercore given on Tuesday, July 21. Deutsche Bank maintained the shares of CCI in report on Thursday, June 8 with “Buy” rating. The rating was maintained by Citigroup with “Neutral” on Monday, August 28.

More notable recent Crown Castle International Corp. (NYSE:REIT) news were published by: Fool.com which released: “Better Buy: Realty Income vs. Store Capital – The Motley Fool” on February 10, 2019, also Forbes.com with their article: “5 REITs With Impressive Dividend Growth – Forbes” published on January 14, 2019, Globenewswire.com published: “ARMOUR Residential REIT, Inc. Announces Public Offering of 5000000 Shares of Common Stock – GlobeNewswire” on January 14, 2019. More interesting news about Crown Castle International Corp. (NYSE:REIT) were released by: Seekingalpha.com and their article: “Stag Industrial: A REIT With A Strategy – Seeking Alpha” published on January 23, 2019 as well as Philly.com‘s news article titled: “The student-run Drexel Dragon Fund presents best investment ideas at NYSE – Philly.com” with publication date: January 28, 2019.

Ashfield Capital Partners Llc, which manages about $2.94B and $892.15 million US Long portfolio, decreased its stake in General Electric Co (NYSE:GE) by 39,352 shares to 213,997 shares, valued at $2.42 million in 2018Q3, according to the filing. It also reduced its holding in Apple Inc (NASDAQ:AAPL) by 2,734 shares in the quarter, leaving it with 235,071 shares, and cut its stake in Ishares Tr (EFA).

Investors sentiment increased to 1.08 in 2018 Q3. Its up 0.02, from 1.06 in 2018Q2. It improved, as 29 investors sold CCI shares while 234 reduced holdings. 86 funds opened positions while 198 raised stakes. 377.74 million shares or 1.71% less from 384.32 million shares in 2018Q2 were reported. Robeco Institutional Asset Management Bv holds 17,991 shares or 0.01% of its portfolio. Artemis Investment Mgmt Ltd Liability Partnership owns 588,472 shares. Quantbot Techs Limited Partnership invested in 0.47% or 60,553 shares. Davis Selected Advisers holds 0.06% or 129,918 shares in its portfolio. Arizona State Retirement holds 0.11% in Crown Castle International Corp. (NYSE:REIT) or 102,820 shares. Quantres Asset Mgmt invested 0.38% in Crown Castle International Corp. (NYSE:REIT). Peapack Gladstone Fincl invested 0.07% in Crown Castle International Corp. (NYSE:REIT). 1.53M are owned by Ubs Asset Mgmt Americas Incorporated. Pub Employees Retirement Association Of Colorado invested in 73,761 shares. Mig Capital reported 3.44% of its portfolio in Crown Castle International Corp. (NYSE:REIT). Parametric Portfolio Associates Ltd Llc owns 1.25 million shares. Td Asset owns 585,267 shares for 0.1% of their portfolio. Ntv Asset Mngmt Lc accumulated 13,092 shares. Citadel Advsr Ltd reported 375,805 shares stake. Ironwood Finance Lc accumulated 150 shares or 0.01% of the stock.

ABIOMED, Inc. (NASDAQ:ABMD) Institutional Positions Chart